Uniray Life Sciences

Powered by Moxifloxacin – 4th Generation Fluoroquinolone

A unique intrauterine formulation combining a potent 4th generation antibiotic (Moxifloxacin), antiprotozoal agents, Vitamin E, and citrus bioflavonoids, delivered in an advanced foam base for optimal dispersion and retention within the uterine cavity.

Moxifloxacin is a broad-spectrum 4th generation fluoroquinolone antibiotic known for its superior efficacy against both Gram-positive and Gram-negative bacteria, including resistant strains. Its excellent tissue penetration and anti-inflammatory properties make it the preferred choice for uterine infections in large animals.

• Infertility / Repeat Breeding

• Pyometra

• Metritis / Endometritis

• Retention of Placenta (ROP)

• Cervicitis & Vaginitis

• Delayed Uterine Involution

• Prolapse of Uterus or Vagina

• pH Imbalance in Uterine Environment

• Antiprotozoal Activity: Targets protozoal infections that may coexist with bacterial uterine infections.

• Vitamin E: Supports tissue repair and reduces oxidative stress in the reproductive tract.

• Citrus Bioflavonoids: Natural antioxidants that enhance capillary integrity and support immune response.

• Foam Base Delivery: Ensures even distribution, better contact time, and improved retention in the uterus.

• 🌟 Best-in-Class Antibiotic Action

• 🌟 Broad-spectrum activity against pathogens causing uterine infections

• 🌟 Improves conception rates by restoring uterine health

• 🌟 Supports faster uterine recovery postpartum